Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Potassium-competitive Acid Blocker Versus Double Dose Proton Pump Inhibitors in High High-risk Peptic Ulcer Bleeding
NCT07772700Not yet recruiting
- Sponsor
- National Cheng Kung University Hospital
- Start
- Sep 2026
- Primary completion
- Dec 2027
01
Overview
Randomised trial of vonoprazan in peptic ulcer disease (PUD) (2 arms), sponsored by National Cheng Kung University Hospital. Primary endpoint: Recurrent bleeding at 28 days. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
vonoprazan
03
Conditions
peptic ulcer disease (PUD)
Beyond the preview
Go deeper on NCT07772700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07772700.